Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Pierre Jacquet currently holds 45,000 shares of Mereo BioPharma Group plc (MREO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pierre Jacquet has been a net neutral trader of MREO stock. They have purchased $0 and sold $0 worth of shares.
Pierre Jacquet's most recent insider trade was on Feb 8, 2024, when they sold 45,000 shares at $0.00 per share.
Pierre Jacquet serves as Executive at Mereo BioPharma Group plc (MREO). They have executed 9 insider transactions totaling $0 over their tenure at the company.
Pierre Jacquet holds the position of Executive at Mereo BioPharma Group plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Pierre Jacquet has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Pierre Jacquet was on Feb 8, 2024, when they purchased $0 worth of MREO shares. This transaction involved 45,000 shares at N/A per share.
Pierre Jacquet currently owns 45,000 shares of Mereo BioPharma Group plc (MREO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Pierre Jacquet's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Pierre Jacquet has 9 Form 4 filings on record as an insider at Mereo BioPharma Group plc.
Set alerts for Pierre Jacquet and 40,000+ other insiders.